Lowenstein Sandler is representing long-time client, Indorama Ventures Public Company Limited, in the proposed acquisition of a Decatur, Alabama manufacturing facility from BP Amoco Chemical Company. The definitive purchase agreement for the 1,000-acre, 450-employee facility was signed on January 6, 2016. The acquisition of the Decatur facility is the sixth investment in North America in which Lowenstein represented Indorama and the second in the past year. In 2007, Lowenstein represented Indorama in acquiring the land rights and raw material supply agreement from BP to build its AlphaPet plant, which is co-located at the Decatur site. The Lowenstein team was led by partner Nicholas San Filippo IV, and included Nicholas Mehler, Christine Osvald-Mruz, Brian Silikovitz, Norman Spindel, Stuart Yusem, Sam Khan, Ethan Skerry, Lesley Pruzansky Adamo, Eugene Cheval, Robert Bee, and Meredith Jewitt.
Relevant Insights
-
PROFESSIONALS | Lawyers
Access the profiles of the more than 350 Lowenstein Sandler lawyers who provide critical legal counsel to clients in virtually every sector of the global economy...
-
NEWS & INSIGHTS | Firm News
Discover the latest updates and developments about Lowenstein Sandler...
-
NEWS & INSIGHTS | Publications
Access our insightful thought leadership, including articles, client alerts, and blog posts...